This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2007-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2017
Title: Innovations by Richard O'Brien in Alzheimer's Disease Diagnosis
Introduction
Richard O'Brien is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. With a total of 2 patents, O'Brien's work focuses on innovative methods for diagnosing and assessing Alzheimer's disease.
Latest Patents
One of O'Brien's latest patents is a diagnostic assay for Alzheimer's disease. This invention provides methods and compositions that are useful in diagnosing and assessing Alzheimer's disease (AD). The method involves obtaining a cerebrospinal fluid (CSF) sample from a patient, adding isotopically labeled peptides identical to portions of biomarker proteins, and measuring these proteins using mass spectrometry. The levels of these proteins compared to a control correlate with the presence of AD in the patient.
Another notable patent is a method for identifying compounds that affect ionotropic glutamate receptor aggregation. This method identifies compounds that influence the formation of AMPA receptors into aggregates. It also provides for a compound, such as a long pentraxin polypeptide, that has a pentraxin binding domain and affects AMPA receptor aggregation of GluR1, GluR2, and GluR3 receptor subunits.
Career Highlights
Richard O'Brien is affiliated with Johns Hopkins University, where he continues to advance research in the field of Alzheimer's disease and related areas. His work has garnered attention for its potential impact on diagnosing and treating neurodegenerative diseases.
Collaborations
O'Brien has collaborated with notable colleagues, including Jennifer E Van Eyk and Xiaogian Liu. These collaborations have contributed to the development of innovative diagnostic methods and further research in the field.
Conclusion
Richard O'Brien's contributions to the field of Alzheimer's disease diagnosis through his innovative patents highlight the importance of research in medical science. His work not only enhances our understanding of Alzheimer's disease but also paves the way for improved diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile